Publisher: Icon Group International, Inc.
Category: Drug Discovery

Drug Discovery market research reports by Icon Group International, Inc.

(361 reports matching your criteria)
    • The 2025-2030 World Outlook for Ophthalmic Disease Therapeutics

      The 2025-2030 World Outlook for Ophthalmic Disease Therapeutics This study covers the world outlook for ophthalmic disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Rosacea Therapeutics

      The 2025-2030 World Outlook for Rosacea Therapeutics This study covers the world outlook for rosacea therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Topical Pigmentation Disorders Treatment Drugs

      The 2025-2030 World Outlook for Topical Pigmentation Disorders Treatment Drugs This study covers the world outlook for topical pigmentation disorders treatment drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More

    • The 2025-2030 World Outlook for Tinnitus Management

      The 2025-2030 World Outlook for Tinnitus Management This study covers the world outlook for tinnitus management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Melanoma Therapeutics

      The 2025-2030 World Outlook for Melanoma Therapeutics This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments

      The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments This study covers the world outlook for disease-specific chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More

    • The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

      The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments

      The 2025-2030 World Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments This study covers the world outlook for IBD (ulcerative colitis and Crohn's disease) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More

    • The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics

      The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics This study covers the world outlook for aldosterone-antagonist dilated cardiomyopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potentia ... Read More

    • The 2025-2030 World Outlook for Prostaglandin Glaucoma Therapeutics

      The 2025-2030 World Outlook for Prostaglandin Glaucoma Therapeutics This study covers the world outlook for prostaglandin glaucoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Prostate Cancer Therapeutics

      The 2025-2030 World Outlook for Prostate Cancer Therapeutics This study covers the world outlook for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Women's Health Therapeutics

      The 2025-2030 World Outlook for Women's Health Therapeutics This study covers the world outlook for women's health therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Substance Abuse Therapeutics

      The 2025-2030 World Outlook for Substance Abuse Therapeutics This study covers the world outlook for substance abuse therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Cancer-Treating Drugs

      The 2025-2030 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics

      The 2025-2030 World Outlook for Autism Spectrum Disorder Therapeutics This study covers the world outlook for autism spectrum disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Autism Therapies

      The 2025-2030 World Outlook for Autism Therapies This study covers the world outlook for autism therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Liver Cancer Drugs

      The 2025-2030 World Outlook for Liver Cancer Drugs This study covers the world outlook for liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Hepatitis C Treatments

      The 2025-2030 World Outlook for Hepatitis C Treatments This study covers the world outlook for hepatitis c treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Hepatitis Therapeutics

      The 2025-2030 World Outlook for Hepatitis Therapeutics This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for RNA-Based Therapeutics

      The 2025-2030 World Outlook for RNA-Based Therapeutics This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Aneurysmal Subarachnoid Hemorrhage Drugs

      The 2025-2030 World Outlook for Aneurysmal Subarachnoid Hemorrhage Drugs This study covers the world outlook for aneurysmal subarachnoid hemorrhage drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More

    • The 2025-2030 World Outlook for Oral Anti Diabetes Drugs

      The 2025-2030 World Outlook for Oral Anti Diabetes Drugs This study covers the world outlook for oral anti diabetes drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Companion Animal Postoperative Pain Management Therapeutics

      The 2025-2030 World Outlook for Companion Animal Postoperative Pain Management Therapeutics This study covers the world outlook for companion animal postoperative pain management therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potent ... Read More

    • The 2025-2030 World Outlook for Exosome Therapeutics

      The 2025-2030 World Outlook for Exosome Therapeutics This study covers the world outlook for exosome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs

      The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs This study covers the world outlook for inhalation and nasal spray generic corticosteroid drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More

1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings